FDA clears LabCorp’s COVID-19 home collection kits as Congress looks to bolster testing with $25B

LabCorp became the first diagnostic company to have an at-home collection kit for COVID-19 authorized by FDA, a month after the agency cleared its lab PCR test for the novel coronavirus. FDA also gave a green light to a Phase II trial of aTyr’s fusion protein Tuesday to treat COVID-19 patients with severe respiratory complications.

Laboratory Corp. of America Holdings (NYSE:LH) plans to make its home collection kits available in most states, with a doctor’s order, in the coming weeks. After collecting a nasal sample by self-swabbing, a user would mail their sample in an insulated package to a LabCorp lab for testing. ...